IE
LVTX

Israel Englander’s LAVA Therapeutics LVTX Stock Holding History

Israel Englander’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,604
Closed -$18.6K – 6180
2024
Q4 		$18.6K Buy
19,604
+7,541
+63% +$11.8K ﹤0.01% 5717
2024
Q3 		$20K Sell
12,063
-14,430
-54% -$26.4K ﹤0.01% 5801
2024
Q2 		$47.7K Buy
26,493
+6,465
+32% +$17.1K ﹤0.01% 5422
2024
Q1 		$66.7K Sell
20,028
-8,035
-29% -$17.7K ﹤0.01% 5647
2023
Q4 		$44.3K Sell
28,063
-35,946
-56% -$51.3K ﹤0.01% 5500
2023
Q3 		$95.4K Sell
64,009
-16,365
-20% -$29.3K ﹤0.01% 5354
2023
Q2 		$163K Buy
+80,374
New +$148K ﹤0.01% 5195
2022
Q4 		– Sell
-39,163
Closed -$179K – 6830
2022
Q3 		$179K Sell
39,163
-57,242
-59% -$158K ﹤0.01% 5715
2022
Q2 		$276K Sell
96,405
-54,225
-36% -$188K ﹤0.01% 5436
2022
Q1 		$663K Buy
150,630
+109,392
+265% +$556K ﹤0.01% 4895
2021
Q4 		$227K Sell
41,238
-30,595
-43% -$201K ﹤0.01% 5799
2021
Q3 		$425K Sell
71,833
-66,998
-48% -$482K ﹤0.01% 5496
2021
Q2 		$1.51M Sell
138,831
-87,374
-39% -$1.08M ﹤0.01% 4258
2021
Q1 		$3.44M Buy
+226,205
New +$3.11M ﹤0.01% 2993

Other funds holding LVTX

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
MC
Merck & Co Rahway, New Jersey $526M AUM 175.27% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $369M AUM 50.95% 1-Year Est. Return
PFA
Pathway Financial Advisors South Burlington, Vermont $857M AUM 17.21% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Israel Englander's LVTX Position: Q1 2025 in Review

Israel Englander sold out of LAVA Therapeutics (LVTX) in Q1 2025, closing a stake of 19,604 shares — an estimated $18.6K sold.

Israel Englander first reported a position in LVTX in Q1 2021 and held it in 14 quarters. The position peaked at $3.44M in Q1 2021. 20 funds tracked by Wall St. Rank hold LVTX as of Q1 2025.

  • Israel Englander reported no remaining LAVA Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Israel Englander sold 19,604 LAVA Therapeutics shares in Q1 2025, an estimated $18.6K.
  • Israel Englander first reported a position in LAVA Therapeutics in Q1 2021 and held it in 14 quarters.
  • Israel Englander's LAVA Therapeutics position peaked at $3.44M in Q1 2021.
  • 20 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.